Journal of Brain and Neurology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Rapid Communication - Journal of Brain and Neurology (2025) Volume 8, Issue 2

Advances and implications of neurogenesis in modern medicine.

Samu chamo*

Department of Neuroscience, University of Virginia, USA

*Corresponding Author:
Samu chamo
Department of Neuroscience
University of Virginia, USA
E-mail: swN@virginia.edu

Received: 01-May-2025, Manuscript No. AAJBN-25-171406; Editor assigned: 05-May-2025, Pre QC No. AAJBN-25-171406 (PQ); Reviewed: 17-May-2025, QC No. AAJBN-25-171406; Revised: 24-May-2025, Manuscript No. AAJBN-25-171406 (R); Published: 31-May-2025, DOI: 10.35841/aajbn-8.2.197

Citation: Chamo S. Advances and implications of neurogenesis in modern medicine. J Brain Neurol. 2025;8(2):197

Visit for more related articles at Journal of Brain and Neurology

Introduction

Neurogenetics is an interdisciplinary field that explores the intricate relationship between genetics and the nervous system. By examining how genetic variations influence neural development, function, and susceptibility to neurological disorders, this field provides critical insights into the mechanisms underlying brain health and disease. The study of neurogenetics has expanded rapidly in recent years, driven by advances in genome sequencing, bioinformatics, and molecular biology, allowing scientists to identify specific genes associated with various neurological conditions. [1].

One of the primary focuses of neurogenetics is understanding hereditary neurological disorders. Conditions such as Huntington’s disease, familial forms of epilepsy, and certain types of ataxia have been linked to mutations in specific genes. Identification of these mutations not only enhances diagnostic accuracy but also enables early intervention strategies and informed genetic counseling for affected families. As research progresses, it has become clear that even complex, multifactorial disorders like Alzheimer’s disease and Parkinson’s disease have significant genetic components that influence disease onset and progression. [2].

In addition to hereditary disorders, neurogenetics plays a vital role in unraveling the genetic factors contributing to psychiatric conditions. Schizophrenia, bipolar disorder, and autism spectrum disorders have all been associated with a combination of genetic variants and environmental influences. Through genome-wide association studies and epigenetic research, scientists are beginning to map the complex networks of genes that affect brain function and behavior. Understanding these genetic underpinnings can pave the way for personalized treatment approaches, minimizing adverse effects and improving patient outcomes.[3].

Technological advancements have significantly accelerated neurogenetic research. Techniques such as CRISPR-Cas9 gene editing, whole-genome sequencing, and single-cell RNA analysis allow researchers to investigate the functional impact of genetic variations at unprecedented resolution. Animal models and induced pluripotent stem cells derived from patients provide platforms to study disease mechanisms and test potential therapeutic interventions. These innovations are bridging the gap between genetic discoveries and clinical applications, offering hope for more targeted and effective treatments for neurological disorders. [4].

Ethical considerations are an essential aspect of neurogenetics. Genetic testing for neurological conditions raises questions about privacy, informed consent, and potential discrimination. Additionally, interventions that manipulate the human genome, while promising, carry the risk of unforeseen consequences. Ethical frameworks and regulatory policies must evolve alongside scientific progress to ensure responsible application of neurogenetic knowledge, balancing potential benefits with societal and individual risks. [5].

Conclusion

Neurogenetics holds immense promise for the future of neurology and medicine. By integrating genetic insights with clinical practice, researchers and clinicians can develop predictive models for disease risk, design personalized therapies, and even explore strategies for prevention. Continued investment in research, collaboration across disciplines, and careful consideration of ethical implications will be key to realizing the full potential of neurogenetics in improving neurological health and patient care worldwide.

References

  1. Karten HJ, Shimizu T. The origins of neocortex: Connections and lamination as distinct events in evolution. J Cogn Neurosci. 1989;1:291-301.

    2. Indexed at, Google Scholar, Cross Ref

  2. Youngren OM, Phillips RE. A stereotaxic atlas of the brain of the three-day-old domestic chick. J Comp Neurol. 1978;181:567-99.

    3. Indexed at, Google Scholar, Cross Ref

  3. Karten HJ. Evolutionary developmental biology meets the brain: The origins of mammalian cortex. Proc Natl Acad Sci USA. 1997;94:2800-04.

    4. Indexed at, Google Scholar, Cross Ref

  4. Phillips RE. A stereotaxic atlas of the brain of the three-day-old domestic chick. J Comp Neurol. 1978;181:567-99.

    5. Indexed at, Google Scholar, Cross Ref

  5. Wijdicks EF. 10 questions about the clinical determination of brain death. Neurol. 2007;13:380-1.

    6. Indexed at, Google Scholar, Cross Ref

Get the App